MBX MBX Biosciences, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
00:00
Jun 24
seedy19tron Biotech trader, L/S
UBS analyst Mike Yee named MBX as a hot takeover target alongside COGT and APGE; no personal position disclosed by author.
MBX
MED
20:05
Dec 22
1. THE FACT: Minervini's longs have been "performing really well." Top gainers include: $MBX, $NEM, $ATI, $ROIV, $DRD and $TSLA. "All but one of our 10 longs are positive." 2. THE BRIDGE: Strong performance and positive returns on these individual long positions indicate upward momentum and potential for continued gains, even in a market that feels "heavy" (as mentioned in tweet 4). This suggests these stocks are showing relative strength. 3. THE VERDICT: Long MBX, NEM, ATI, ROIV, DRD, and TSLA due to strong recent performance.
MBX 1ST
HIGH

About MBX Analyst Coverage

Buzzberg tracks MBX (MBX Biosciences, Inc. Common Stock) across 2 sources. 1 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (50%). 2 total trade ideas tracked. Latest voices: seedy19tron, @markminervini.